Residency · Saint Louis, MO
Sponsored by SSM Health/Saint Louis University School of Medicine
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2022 · 231 citations · Elaine Siegfried
Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations.
The Lancet. Oncology · 2024 · 64 citations · Xin Wu
The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature.
American journal of clinical dermatology · 2023 · 40 citations · Geoffrey Potts
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial.
JAMA dermatology · 2021 · 138 citations · Elaine Siegfried
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
JAMA dermatology · 2023 · 64 citations · Elaine Siegfried
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study.
American journal of clinical dermatology · 2024 · 39 citations ·
Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials.
The Journal of dermatological treatment · 2022 · 42 citations · George Lewitt
Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease.
The Journal of clinical investigation · 2021 · 83 citations · George Denny